lixte.com valuation and analysis

Robots.txt Information
Robot Path Permission
GoogleBot / ✔
BingBot / ✔
BaiduSpider / ✔
YandexBot / ✔ 
# START YOAST BLOCK # --------------------------- User-agent: * Disallow: Sitemap: https://lixte.com/sitemap_index.xml # --------------------------- # END YOAST
Meta Tags
Title About LIXTE - Lixte Biotechnology Holdings, Inc.
Description LIXTE Biotechnology Holdings, Inc. (Nasdaq: Dedicated to Creating Better Treatments for
Keywords N/A
Server Information
WebSite lixte faviconlixte.com
Host IP 74.208.236.39
Location United States
Related Websites
Site Rank
More to Explore
lixte.com Valuation
US$6,601,702
Last updated: 2023-05-08 11:20:48

lixte.com has Semrush global rank of 1,603,269. lixte.com has an estimated worth of US$ 6,601,702, based on its estimated Ads revenue. lixte.com receives approximately 761,735 unique visitors each day. Its web server is located in United States, with IP address 74.208.236.39. According to SiteAdvisor, lixte.com is safe to visit.

Traffic & Worth Estimates
Purchase/Sale Value US$6,601,702
Daily Ads Revenue US$6,094
Monthly Ads Revenue US$182,817
Yearly Ads Revenue US$2,193,797
Daily Unique Visitors 50,783
Note: All traffic and earnings values are estimates.
DNS Records
Host Type TTL Data
lixte.com. A 3600 IP: 74.208.236.39
lixte.com. AAAA 86400 IPV6: 2607:f1c0:100f:f000::2c2
lixte.com. NS 86400 NS Record: ns51.1and1.com.
lixte.com. NS 86400 NS Record: ns52.1and1.com.
lixte.com. MX 3600 MX Record: 1 aspmx.l.google.com.
lixte.com. MX 3600 MX Record: 5 alt2.aspmx.l.google.com.
lixte.com. MX 3600 MX Record: 5 alt1.aspmx.l.google.com.
lixte.com. MX 3600 MX Record: 10 alt3.aspmx.l.google.com.
HtmlToTextCheckTime:2023-05-08 11:20:48
About LIXTE Management Board of Directors Forward-Looking Statements Product Development Publications Investor Information About LIXTE Management Board of Directors Forward-Looking Statements Product Development Publications Investor Information ✕ Dedicated to Creating Better Treatments for Cancer LIXTE in the News and Media: LIXTE Biotechnology Reports First Spanish Site Activated to Begin Accrual of Patients for a Phase 1b/2 Clinical Trial of LIXTE’s Lead Anti-Cancer Compound, LB-100, Added to Doxorubicin as First-Line Treatment of Advanced Soft Tissue Sarcoma – LIXTE Biotechnology Holdings, Inc. APRIL 24, 2023 LIXTE Biotechnology Announces Sarah Cannon Research Institute Joins City of Hope’s Ongoing Phase 1b Clinical Trial in Evaluating Lixte’s Lead Anti-Cancer Compound, LB-100, in Small Cell Lung Cancer – LIXTE Biotechnology Holdings, Inc. APRIL 4, 2023 LIXTE BIOTECHNOLOGY HOLDINGS REPORTS NEWLY PUBLISHED INDEPENDENT PRE-CLINICAL RESEARCH – LIXTE Biotechnology Holdings, Inc.
HTTP Headers
HTTP/1.1 301 Moved Permanently
Content-Type: text/html; charset=UTF-8
Connection: keep-alive
Keep-Alive: timeout=15
Date: Fri, 29 Oct 2021 22:42:29 GMT
Server: Apache
X-Redirect-By: WordPress
Location: https://lixte.com/

HTTP/2 200 
content-type: text/html; charset=UTF-8
date: Fri, 29 Oct 2021 22:42:29 GMT
server: Apache
link: ; rel="https://api.w.org/", ; rel="alternate"; type="application/json", ; rel=shortlink
lixte.com Whois Information
Domain Name: LIXTE.COM
Registry Domain ID: 190977448_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.tucows.com
Registrar URL: http://www.tucows.com
Updated Date: 2021-06-30T05:00:53Z
Creation Date: 2005-07-29T18:18:08Z
Registry Expiry Date: 2022-07-29T18:18:08Z
Registrar: Tucows Domains Inc.
Registrar IANA ID: 69
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited
Name Server: NS51.1AND1.COM
Name Server: NS52.1AND1.COM
DNSSEC: unsigned
>>> Last update of whois database: 2021-09-17T10:37:32Z <<<

Copyright © 2022 WebZZ.US 0.0175